SOSolventum SOLV · NYSE
$85.10 -0.83% (-$0.71)
- Market cap
- $14.5B
- Enterprise value
- $19.4B
- P/E
- 10.1x
- Forward P/E
- 11.6x
- PEG
- 0.0x
- P/S
- 1.7x
- P/FCF
- -
- EV/EBITDA
- 7.5x
- ROIC
- 15.9%
- Bruto marža
- 54.7%
- Neto marža
- 17.3%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 1.9x
- Beta
- 0.70
- Free float
- 84.7%
O podjetju
Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Bryan C. Hanson
Employees
20,584
Headquarters
Eagan
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke